AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 58 filers reported holding AURA BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,243,928 | +403.6% | 1,163,123 | +296.5% | 6.09% | +436.0% |
| Q2 2023 | $3,622,663 | +33.1% | 293,333 | 0.0% | 1.14% | +3.5% |
| Q1 2023 | $2,722,130 | -11.6% | 293,333 | 0.0% | 1.10% | -4.8% |
| Q4 2022 | $3,079,997 | -19.1% | 293,333 | +39.7% | 1.15% | -16.4% |
| Q3 2022 | $3,805,000 | +27.9% | 210,000 | 0.0% | 1.38% | +22.3% |
| Q2 2022 | $2,976,000 | -35.6% | 210,000 | 0.0% | 1.13% | -20.3% |
| Q1 2022 | $4,620,000 | – | 210,000 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $51,617,000 | 12.92% |
| Matrix Capital Management Company, LP | 4,112,870 | $69,837,000 | 0.78% |
| Rock Springs Capital Management LP | 1,008,114 | $17,118,000 | 0.40% |
| Nantahala Capital Management | 99,146 | $1,683,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,255,480 | $21,318,000 | 0.04% |
| Citadel Advisors | 2,315,102 | $37,318,000 | 0.01% |
| CAAS CAPITAL MANAGEMENT LP | 10,000 | $170,000 | 0.00% |
| Concord Wealth Partners | 150 | $3,000 | 0.00% |
| Allianz Asset Management GmbH | 55,145 | $936,000 | 0.00% |
| FMR LLC | 471,300 | $8,003,000 | 0.00% |